Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi.
Ballotta L, Zinzani PL, Pileri S, Bruna R, Tani M, Casadei B, Tabanelli V, Volpetti S, Luminari S, Corradini P, Lucchini E, Tisi MC, Merli M, Re A, Varettoni M, Pesce EA, Zaja F. Ballotta L, et al. Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021. Front Oncol. 2021. PMID: 34938664 Free PMC article.
Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.
Ballotta L, Simonetti O, D'Agaro P, Segat L, Koncan R, Martinez-Orellana P, Dattola F, Orsini E, Marcello A, Dal Monego S, Licastro D, Misin A, Mohamed S, Sbisà E, Lucchini E, De Sabbata GM, Zaja F, Luzzati R. Ballotta L, et al. Front Oncol. 2022 Sep 30;12:945060. doi: 10.3389/fonc.2022.945060. eCollection 2022. Front Oncol. 2022. PMID: 36249044 Free PMC article.
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
Bega G, Olivieri J, Riva M, Scapinello G, Paolini R, Finotto S, Sartori R, Lucchini E, Guandalini G, Facchinelli D, Tisi MC, Basso M, Ballotta L, Piazza F, Ferrarini I, Visco C. Bega G, et al. Among authors: ballotta l. Cancers (Basel). 2021 Dec 3;13(23):6089. doi: 10.3390/cancers13236089. Cancers (Basel). 2021. PMID: 34885198 Free PMC article.
Current and future therapeutic approaches for the treatment of follicular lymphoma.
Pulsoni A, Cappelli LV, Ballotta L, Canichella M, Serrao A, Annechini G, D'Elia GM, Foà R. Pulsoni A, et al. Among authors: ballotta l. Expert Rev Anticancer Ther. 2018 Sep;18(9):931-941. doi: 10.1080/14737140.2018.1493926. Epub 2018 Jul 16. Expert Rev Anticancer Ther. 2018. PMID: 29972084 Free article. Review.
BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.
Marchesi F, Capria S, Pedata M, Terrenato I, Ballotta L, Riccardi C, Papa E, Riemma C, Trisolini S, Celentano M, Regazzo G, Ferrara F, Mengarelli A, Picardi A. Marchesi F, et al. Among authors: ballotta l. Leuk Lymphoma. 2020 Sep;61(9):2238-2241. doi: 10.1080/10428194.2020.1765238. Epub 2020 May 18. Leuk Lymphoma. 2020. PMID: 32419550 No abstract available.
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".
Mohamed S, Lucchini E, Sirianni F, Porrazzo M, Ballotta L, Ballerini M, De Sabbata GM, De Bellis E, Cappuccio I, Granzotto M, Toffoletto B, Fortunati I, Russignan A, Florea EE, Torelli L, Zaja F. Mohamed S, et al. Among authors: ballotta l. Front Oncol. 2023 Feb 27;13:1133348. doi: 10.3389/fonc.2023.1133348. eCollection 2023. Front Oncol. 2023. PMID: 36923438 Free PMC article.
11 results